News

Mylan NV's new drug application for its combo regimen of dolutegravir, emtricitabine, and tenofovir alafenamide, received tentative approval from the US Food and Drug Administration under the President's Emergency Plan for AIDS Relief (PEPFAR).

A new study announced by the National Institute of Allergy and Infectious Diseases may help cut the number of antibiotics unnecessarily prescribed for viral lower respiratory tract infections.

A molecule capable of clearing HSV-1 infection in the cells of the cornea could be a promising potential option for those who have developed resistance to current drugs.

A recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.

Massive vaccination campaigns launched in Brazil and Nigeria strive to quell ongoing outbreaks.

A recent report documents the first recorded case of a human infestation with the cattle eyeworm Thelazia gulosa.

Can culturing process changes reduce the impact of catheter-associated urinary tract infections (CAUTIs)?

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Providing investments in 10 vaccines during a 15-year period in low- and middle-income nations could prevent 36 million deaths and 24 million cases of poverty related to medical reasons.

Although rare, children inoculated against chicken pox can present with herpes zoster at or near the vaccination site.

The latest data from the Centers for Disease Control and Prevention have revealed that adults who are vaccinated are 36% less likely to get the flu. That number jumps to a whopping 59% for young children.

A panel of experts from the Philippines Department of Health finds that Sanofi Pasteur's dengue fever vaccine, Dengvaxia (CYD-TDV), may be connected with 3 deaths.

Fecal transplantation and molecular testing are among the new recommendations.

Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.

Infectious disease specialists and public health professionals in search of a to-do list for 2018 need look no further.

Recognition of chronic Lyme disease and the role of long-term antibiotic treatment for persistent symptoms continue to be controversial among researchers, providers, patients, and advocates.

ViiV Healthcare has launched a phase 3 study to assess if adults with HIV-1 who have achieved viral suppression on a 3-drug regimen can maintain suppression when switched to a 2-drug regimen.

Efforts to curb antimicrobial resistance have hit a brick wall in India, where new research finds unapproved drug combinations are rampant.

A new systematic review of published research suggests that methotrexate could potentially be the best co-treatment option for chronic arthritis associated with the chikungunya virus.

The FDA has granted pre-market approval for a new HPV test that can detect and identify HPV genotypes that put women at increased risk for cervical cancer.

An international research team finds that targeting the social and risk networks of patients recently diagnosed with HIV is leading them to more patients unknowingly infected with the virus.

Was the situation in Flint, Michigan an outlier or an ominous warning of what’s to come?

A Nebraska mother’s Facebook post has parents and health experts around the country wondering if an influenza B infection may have caused hives in a child who did not present with any other flu symptoms.

The Rhode Island Department of Health has issued a consumer alert regarding deli sliced meat and cheese sold at a local Stop & Shop due to potential Listeria contamination.

Following an outbreak of norovirus in Pyeongchang ahead of the Winter Olympics, health officials are taking steps to stem the outbreak and keep attendees healthy.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

In case you missed them, we've compiled a list of the latest US Food and Drug Administration (FDA) recalls posted this week.

The CDC’s acting director provides a somber flu update and stresses the need to stay vigilant against the virus.

A small portion of individuals with Lyme disease continue to have symptoms of arthritis long after treatment. Now, scientists think they have a better understanding of the cause of that lingering reaction.